Cardiovascular risks in HIV: interview with Dr. Steven Grinspoon from Harvard Medical School
The Forum for Collaborative HIV Research held an open meeting in Washington, DC last week to discuss cardiovascular risk in HIV. The meeting featured experts from FDA, EMA (FDA’s European equivalent), academia, industry and community groups. Dr. Steven Grinspoon, professor of medicine at Harvard Medical School, spoke at the meeting about the clinical implications of the findings.
In this podcast interview Dr. Grinspoon discusses the following topics:
Why the topic of cardiovascular risk in HIV is coming up for discussion now
The magnitude of the risk and how it varies by age and sex
The role of traditional risk factors (such as smoking) and non-traditional factors
Implications for HIV patients and their physicians
3 thoughts on “Cardiovascular risks in HIV: interview with Dr. Steven Grinspoon from Harvard Medical School”